Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
March 31, 2017The Lancet OncologyOpen Access

Avelumab for metastatic or locally advanced previously treated solid tumours (JAVELIN Solid Tumor): a phase 1a, multicohort, dose-escalation trial

View Full Paper
Ask AI
Bookmark
Share

Authors

CHChristopher R. HeeryGCGeraldine O’Sullivan CoyneRMRavi A. Madan

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Heery et al. (2017) studied this question.

synapsesocial.com/papers/6a16fe3e2fcf950e0005860fhttps://doi.org/10.1016/s1470-2045(17)30239-5
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer2015 · 6,311 citations
  2. 2Acute effects of alemtuzumab infusion in patients with active relapsing-remitting MS2016 · 76 citations
  3. 3Thymoma-Associated Paraneoplastic Polymyositis2010 · 10 citations
  4. 4A fully human IgG1 anti‐PD‐L1 MAb in an <i>in vitro</i> assay enhances antigen‐specific T‐cell responses2016 · 55 citations
  5. 5Framework selection can influence pharmacokinetics of a humanized therapeutic antibody through differences in molecule charge2014 · 123 citations